Literature DB >> 10935021

A specific role for cyclin D1 in mammary gland development.

P Sicinski1, R A Weinberg.   

Abstract

Cyclin D1 is a critical component of the core cell cycle machinery. Mice lacking cyclin D1 develop mammary glands that fail to undergo normal lobuloalveolar proliferation during pregnancy. Thus, cyclin D1 seems to play a critical role in pregnancy-induced proliferation of mammary epithelium. Cyclin D1 also participates in neoplasia, as the majority of human mammary carcinomas contain elevated levels of this cyclin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10935021     DOI: 10.1023/a:1026391128117

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  36 in total

Review 1.  Developing a mammary gland is a stat affair.

Authors:  L Hennighausen; G W Robinson; K U Wagner; X Liu
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

2.  Progesterone action in normal mouse mammary gland.

Authors:  S Wang; L J Counterman; S Z Haslam
Journal:  Endocrinology       Date:  1990-11       Impact factor: 4.736

3.  17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells.

Authors:  L Altucci; R Addeo; L Cicatiello; S Dauvois; M G Parker; M Truss; M Beato; V Sica; F Bresciani; A Weisz
Journal:  Oncogene       Date:  1996-06-06       Impact factor: 9.867

4.  Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.

Authors:  T C Wang; R D Cardiff; L Zukerberg; E Lees; A Arnold; E V Schmidt
Journal:  Nature       Date:  1994-06-23       Impact factor: 49.962

5.  Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle.

Authors:  E A Musgrove; C S Lee; M F Buckley; R L Sutherland
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

6.  Cyclin D1 and prognosis in human breast cancer.

Authors:  C Gillett; P Smith; W Gregory; M Richards; R Millis; G Peters; D Barnes
Journal:  Int J Cancer       Date:  1996-04-22       Impact factor: 7.396

7.  Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.

Authors:  C Gillett; V Fantl; R Smith; C Fisher; J Bartek; C Dickson; D Barnes; G Peters
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

8.  Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis.

Authors:  J Bartkova; J Lukas; M Strauss; J Bartek
Journal:  Oncogene       Date:  1995-02-16       Impact factor: 9.867

9.  The int-2 gene product acts as an epithelial growth factor in transgenic mice.

Authors:  W J Muller; F S Lee; C Dickson; G Peters; P Pattengale; P Leder
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

10.  A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer.

Authors:  R Michalides; P Hageman; H van Tinteren; L Houben; E Wientjens; R Klompmaker; J Peterse
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

View more
  22 in total

Review 1.  Mammary gland development and tumorigenesis in estrogen receptor knockout mice.

Authors:  W P Bocchinfuso; K S Korach
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

Review 2.  Use of PRKO mice to study the role of progesterone in mammary gland development.

Authors:  R C Humphreys; J P Lydon; B W O'Malley; J M Rosen
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

Review 3.  Cell cycle genes in a mouse mammary hyperplasia model.

Authors:  Thenaa K Said; Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

Review 4.  Growth factor regulation of cell cycle progression in mammary epithelial cells.

Authors:  Malinda A Stull; Anne M Rowzee; Aimee V Loladze; Teresa L Wood
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

5.  Segment- and cell-specific expression of D-type cyclins in the postnatal mouse epididymis.

Authors:  Huizhen Wang; T Rajendra Kumar
Journal:  Gene Expr Patterns       Date:  2012-01-24       Impact factor: 1.224

6.  Cyclin D1 determines mitochondrial function in vivo.

Authors:  Toshiyuki Sakamaki; Mathew C Casimiro; Xiaoming Ju; Andrew A Quong; Sanjay Katiyar; Manran Liu; Xuanmao Jiao; Anping Li; Xueping Zhang; Yinan Lu; Chenguang Wang; Stephen Byers; Robert Nicholson; Todd Link; Melvin Shemluck; Jianguo Yang; Stanley T Fricke; Phyllis M Novikoff; Alexandros Papanikolaou; Andrew Arnold; Christopher Albanese; Richard Pestell
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

7.  Overexpression of aromatase leads to development of testicular leydig cell tumors : an in vivo model for hormone-mediated TesticularCancer.

Authors:  K A Fowler; K Gill; N Kirma; D L Dillehay; R R Tekmal
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

8.  ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells.

Authors:  Rebecca S Muraoka; Anne E G Lenferink; Brian Law; Elizabeth Hamilton; Dana M Brantley; L Renee Roebuck; Carlos L Arteaga
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

9.  Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2.

Authors:  Lisa K Pierson-Mullany; Carol A Lange
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

10.  Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development.

Authors:  Mark D Aupperlee; Alexis A Drolet; Srinivasan Durairaj; Weizhong Wang; Richard C Schwartz; Sandra Z Haslam
Journal:  Endocrinology       Date:  2008-11-06       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.